from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1292/argS

LFCtreatmentdescriptionclass of inhibitor

-1.518

Amikacinug/mL Amikacintranslation

-0.033

Cap5-10ug/mL Capreomycintranslation

-0.603

Rox10-50 ug/mL Roxithromycintranslation

0.845

SM2-5 ug/mL Streptomycintranslation

-2.656

Tet5-10 ug/mL Tetracyclinetranslation

-0.431

Rif0.2-5ug/mL Rifampicintranscription

0.337

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.084

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.461

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.687

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.024

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.842

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.084

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.758

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.942

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.442

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.478

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.621

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.513

Nigericin50 uM Nigericinrespiration

-0.327

TRC10-150 ug/mL Triclosanrespiration

-0.063

TRZ10-25 ug/mL Thioridazinerespiration

-0.653

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.374

menadione6-10 ug/mL Menadionerespiration

0.292

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.184

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.001

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.039

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.796

NRP_1Non-replicating persistence stage 1dosRassociated

0.248

Amp0.2mg/mL AmpicillincellWall

0.715

Cephalexin20-100 ug/mL CephalexincellWall

0.891

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.010

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.579

EMB10-20 ug/mL EthambutolcellWall

0.809

Eta12-40 ug/mL EthionamidecellWall

0.606

INH0.2-0.4 ug/mL IsoniazidcellWall

0.923

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.070

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.258

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.734

BZA0.12 mg/mL BenzamidearomaticAmides

-0.199

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.552

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.380

H2O24 mM hydrogen peroxideDNAdamaging

0.735

Levo10 ug/mL LevofloxacinDNAdamaging

0.483

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.768

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.957

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.139

UVUV-irradiationDNAdamaging

0.303

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.256

Antimycin12.5-50 ug/mL Antimycin A?

-1.689

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.001

PA_110-50 ug/mL Antitubercular compound PA-1?

0.283

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.784

PA8240.2-2 ug/mL PA-824?

0.542

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.806

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.107

Verapamil50 uM Verapamil?

-1.036

mercaptoethanol2 mM 2-Mercaptoethanol?

0.313

methoxatin10-20 ug/mL Methoxatin?